Colonial Trust CO / Sc Laboratory Corp Of America Holdings Transaction History

Colonial Trust CO / Sc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$209.01 - $232.56 $16,093 - $17,907	-77 Reduced 5.76%	1,260 $275,000
Q4 2023 Feb 14, 2024	BUY	$197.69 - $227.29 $107,345 - $123,418	543 Added 68.39%	1,337 $303,000
Q3 2023 Nov 13, 2023	BUY	$201.05 - $221.7 $5,227 - $5,764	26 Added 3.39%	794 $159,000
Q2 2023 Aug 14, 2023	BUY	$211.93 - $241.33 $54,254 - $61,780	256 Added 50.0%	768 $185,000
Q1 2023 May 11, 2023	BUY	$213.32 - $257.83 $12,799 - $15,469	60 Added 13.27%	512 $117,000
Q4 2022 Feb 14, 2023	BUY	$203.72 - $248.97 $92,081 - $112,534	452 New	452 $106,000

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $20.5B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Colonial Trust CO / Sc, based on Form 13F filings with the SEC.

Stay updated on Colonial Trust CO / Sc with notifications on news.